PACS Group Net Income
| PACS Stock | 37.81 1.10 2.83% |
As of the 14th of February 2026, PACS owns the market risk adjusted performance of (2.31), and Semi Deviation of 2.42. In respect to fundamental indicators, the technical analysis model allows you to check possible technical drivers of PACS Group, as well as the relationship between them. Please check PACS Group variance, as well as the relationship between the value at risk and skewness to decide if PACS Group is priced fairly, providing market reflects its prevailing price of 37.81 per share. Given that PACS Group has jensen alpha of 2.1, we recommend you to check out PACS's latest market performance to make sure the company can sustain itself in the future.
PACS Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 1.7995 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 49.8 M | 73.3 M | |
| Net Income | 50.2 M | 67.7 M | |
| Net Income Per Share | 0.44 | 0.67 | |
| Net Income Per E B T | 0.63 | 0.72 |
PACS | Net Income | Build AI portfolio with PACS Stock |
The evolution of Net Income for PACS Group provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how PACS compares to historical norms and industry peers.
Latest PACS's Net Income Growth Pattern
Below is the plot of the Net Income of PACS Group over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in PACS Group financial statement analysis. It represents the amount of money remaining after all of PACS Group operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is PACS's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in PACS's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 55.76 M | 10 Years Trend |
|
Net Income |
| Timeline |
PACS Net Income Regression Statistics
| Arithmetic Mean | 59,548,936 | |
| Geometric Mean | 55,676,609 | |
| Coefficient Of Variation | 47.68 | |
| Mean Deviation | 17,926,719 | |
| Median | 47,947,000 | |
| Standard Deviation | 28,392,273 | |
| Sample Variance | 806.1T | |
| Range | 102.5M | |
| R-Value | 0.42 | |
| Mean Square Error | 710.8T | |
| R-Squared | 0.17 | |
| Significance | 0.1 | |
| Slope | 2,340,744 | |
| Total Sum of Squares | 12897.9T |
PACS Net Income History
Other Fundumenentals of PACS Group
PACS Net Income component correlations
PACS Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for PACS is extremely important. It helps to project a fair market value of PACS Stock properly, considering its historical fundamentals such as Net Income. Since PACS's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of PACS's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of PACS's interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Health Care Providers & Services market expansion? Will PACS introduce new products? Factors like these will boost the valuation of PACS. Anticipated expansion of PACS directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about PACS listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Understanding PACS Group requires distinguishing between market price and book value, where the latter reflects PACS's accounting equity. The concept of intrinsic value - what PACS's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push PACS's price substantially above or below its fundamental value.
It's important to distinguish between PACS's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding PACS should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, PACS's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
PACS 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to PACS's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of PACS.
| 11/16/2025 |
| 02/14/2026 |
If you would invest 0.00 in PACS on November 16, 2025 and sell it all today you would earn a total of 0.00 from holding PACS Group or generate 0.0% return on investment in PACS over 90 days. PACS is related to or competes with Morgan Stanley, Stewart Information, Skyward Specialty, WisdomTree, Stifel Financial, Horace Mann, and Perella Weinberg. PACS is entity of United States. It is traded as Stock on NYSE exchange. More
PACS Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure PACS's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess PACS Group upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.57 | |||
| Information Ratio | 0.2049 | |||
| Maximum Drawdown | 63.26 | |||
| Value At Risk | (6.63) | |||
| Potential Upside | 8.95 |
PACS Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for PACS's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as PACS's standard deviation. In reality, there are many statistical measures that can use PACS historical prices to predict the future PACS's volatility.| Risk Adjusted Performance | 0.1803 | |||
| Jensen Alpha | 2.1 | |||
| Total Risk Alpha | 1.33 | |||
| Sortino Ratio | 0.5556 | |||
| Treynor Ratio | (2.32) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of PACS's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
PACS February 14, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1803 | |||
| Market Risk Adjusted Performance | (2.31) | |||
| Mean Deviation | 4.54 | |||
| Semi Deviation | 2.42 | |||
| Downside Deviation | 3.57 | |||
| Coefficient Of Variation | 471.48 | |||
| Standard Deviation | 9.69 | |||
| Variance | 93.97 | |||
| Information Ratio | 0.2049 | |||
| Jensen Alpha | 2.1 | |||
| Total Risk Alpha | 1.33 | |||
| Sortino Ratio | 0.5556 | |||
| Treynor Ratio | (2.32) | |||
| Maximum Drawdown | 63.26 | |||
| Value At Risk | (6.63) | |||
| Potential Upside | 8.95 | |||
| Downside Variance | 12.78 | |||
| Semi Variance | 5.86 | |||
| Expected Short fall | (5.66) | |||
| Skewness | 4.33 | |||
| Kurtosis | 21.22 |
PACS Group Backtested Returns
PACS is somewhat reliable given 3 months investment horizon. PACS Group retains Efficiency (Sharpe Ratio) of 0.21, which implies the company had a 0.21 % return per unit of risk over the last 3 months. We were able to break down twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.7% are justified by taking the suggested risk. Use PACS Group semi deviation of 2.42, and Market Risk Adjusted Performance of (2.31) to evaluate company specific risk that cannot be diversified away. PACS holds a performance score of 16 on a scale of zero to a hundred. The firm owns a Beta (Systematic Risk) of -0.88, which implies possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning PACS are expected to decrease slowly. On the other hand, during market turmoil, PACS is expected to outperform it slightly. Use PACS Group value at risk, and the relationship between the jensen alpha and skewness , to analyze future returns on PACS Group.
Auto-correlation | -0.23 |
Weak reverse predictability
PACS Group has weak reverse predictability. Overlapping area represents the amount of predictability between PACS time series from 16th of November 2025 to 31st of December 2025 and 31st of December 2025 to 14th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of PACS Group price movement. The serial correlation of -0.23 indicates that over 23.0% of current PACS price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.23 | |
| Spearman Rank Test | -0.55 | |
| Residual Average | 0.0 | |
| Price Variance | 6.22 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
PACS Net Interest Income
Net Interest Income |
|
Based on the recorded statements, PACS Group reported net income of 55.76 M. This is 83.66% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The net income for all United States stocks is 90.23% higher than that of the company.
PACS Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PACS's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of PACS could also be used in its relative valuation, which is a method of valuing PACS by comparing valuation metrics of similar companies.PACS is currently under evaluation in net income category among its peers.
PACS ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, PACS's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to PACS's managers, analysts, and investors.Environmental | Governance | Social |
PACS Fundamentals
| Profit Margin | 0.03 % | ||||
| Operating Margin | 0.0007 % | ||||
| Current Valuation | 9.21 B | ||||
| Shares Outstanding | 155.18 M | ||||
| Shares Owned By Insiders | 72.28 % | ||||
| Shares Owned By Institutions | 28.69 % | ||||
| Number Of Shares Shorted | 3.14 M | ||||
| Price To Book | 7.04 X | ||||
| Price To Sales | 1.18 X | ||||
| Revenue | 4.09 B | ||||
| Gross Profit | 519.14 M | ||||
| EBITDA | 186.7 M | ||||
| Net Income | 55.76 M | ||||
| Total Debt | 3.5 B | ||||
| Book Value Per Share | 3.75 X | ||||
| Cash Flow From Operations | 367.34 M | ||||
| Short Ratio | 3.12 X | ||||
| Earnings Per Share | 0.61 X | ||||
| Price To Earnings To Growth | 1.26 X | ||||
| Target Price | 34.67 | ||||
| Number Of Employees | 45.68 K | ||||
| Market Capitalization | 2.24 B | ||||
| Total Asset | 5.24 B | ||||
| Retained Earnings | 118.04 M | ||||
| Working Capital | (40.17 M) | ||||
| Net Asset | 5.24 B |
About PACS Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PACS Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PACS using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PACS Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for PACS Stock Analysis
When running PACS's price analysis, check to measure PACS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PACS is operating at the current time. Most of PACS's value examination focuses on studying past and present price action to predict the probability of PACS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PACS's price. Additionally, you may evaluate how the addition of PACS to your portfolios can decrease your overall portfolio volatility.